Company & Sponsor Intelligence
University of South Florida
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting3
Completed2
Countries1
Therapeutic footprint
alzheimersanxietyocdpain_neuropathysleep_disorders
Indexed studies
NCT03848312Preventing Alzheimer's With Cognitive Training
alzheimers · United StatesPHASE3
alzheimers · United StatesPHASE3
NCT04621721Home-Based Physical Activity Intervention for Taxane-Induced CIPN
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT06410495Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)
sleep_disorders · United StatesNA
sleep_disorders · United StatesNA
NCT06350292SLEEP-COPE: Sleep Intervention for Oppositional Children
sleep_disorders · United StatesNA
sleep_disorders · United StatesNA
NCT01416805Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers
anxiety · United StatesPHASE3
anxiety · United StatesPHASE3
NCT00742664Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
ocd · United StatesPHASE1,PHASE2
ocd · United StatesPHASE1,PHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →